Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 19 results for "jin da xing"

Multicatalyst System in Asymmetric Catalysis

Preface xi Contributors xiv 1 Toward Ideal Asymmetric Catalysis 1 Jian Zhou and Jin-Sheng Yu 1.1 Introduction 1 1.2 Challenges to Realize Ideal Asymmetric Catalysis 7 1.3 Solutions 13 1.4 Borrow Ideas from Nature 22 1.5 Conclusion 32 ... Research and Markets, 1 month ago

Disease strikes rare animal

Jan 4, 8-year-old female Da Bao died of canine distemper in the Shaanxi Rare Wildlife Rescue and Breeding Research Center. On Dec 9, 8-year-old panda Cheng Cheng died of canine distemper in the Shaanxi center. On June 22, 6-year-old panda Xing ... week ago

Attenuation of Glomerular Endothelial Cells from High Glucose-Induced Injury by Blockade of MAD2B

Abstract Background/Aims: To assess the role of mitotic arrest-deficient 2-like protein 2 (MAD2B) in high glucose-induced injury in mouse glomerular endothelial cells (GEnCs). Methods: GEnCs were cultured in vitro , and MAD2B protein levels were ...
 Sexual Development1 month ago

CMGE Guides Below Estimates

China Mobile Games and Entertainment Group Limited ("CMGE" or the "Company") (CMGE), the largest publisher and a leading developer of mobile games in China, today reported its unaudited financial results for the third quarter ended September 30, ...
 Earnings Whispers2 months ago CMGE Reports Third Quarter 2014 Unaudited Financial Results  Stockwatch2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less